isoretronecanol: structure given in first source
ID Source | ID |
---|---|
PubMed CID | 3080563 |
SCHEMBL ID | 19317460 |
MeSH ID | M0147117 |
Synonym |
---|
isoretronecanol |
[(1s,8s)-2,3,5,6,7,8-hexahydro-1h-pyrrolizin-1-yl]methanol |
unii-661h3381js |
1h-pyrrolizine-1-methanol, hexahydro-, (1s-trans)- |
661h3381js , |
526-63-6 |
SCHEMBL19317460 |
1h-pyrrolizine-1-methanol, hexahydro-, (1s,7as)- |
(-)-isoretronecanol |
heliotridane, 9-hydroxy- |
isoretronecanol, (-)- |
2,3,5,6,7,7a.alpha.-hexahydro-1h-pyrrolizine-1.beta.-methanol |
9-hydroxyheliotridane |
DTXSID50200578 |
D74235 |
Q27263929 |
CS-0080635 |
((1s,7as)-hexahydro-1h-pyrrolizin-1-yl)methanol |
[(1s,7as)-hexahydro-1h-pyrrolizin-1-yl]methanol |
AKOS040734790 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |